{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:02:06Z","timestamp":1792555326675,"version":"4.5.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11064-022-03546-8","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T12:02:34Z","timestamp":1644321754000},"page":"1459-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Kynurenine Metabolism and Alzheimer\u2019s Disease: The Potential Targets and Approaches"],"prefix":"10.1007","volume":"47","author":[{"given":"Vivek Kumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirbhay Kumar","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashi","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"issue":"1","key":"3546_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-019-0520-5","volume":"2","author":"S Zhang","year":"2019","unstructured":"Zhang S, Sakuma M, Deora GS et al (2019) A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites. Commun Biol 2(1):1\u201310. https:\/\/doi.org\/10.1038\/s42003-019-0520-5","journal-title":"Commun Biol"},{"issue":"11","key":"3546_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"VL Feigin","year":"2017","unstructured":"Feigin VL, Abajobir AA, Abate KH et al (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877\u2013897. https:\/\/doi.org\/10.1016\/S1474-4422(17)30299-5","journal-title":"Lancet Neurol"},{"key":"3546_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fnins.2019.00604","volume":"13","author":"PS Mihevc","year":"2019","unstructured":"Mihevc PS, Majdi\u010d G (2019) Canine cognitive dysfunction and Alzheimer\u2019s disease\u2013two facets of the same disease? Front Neurosci 13:604. https:\/\/doi.org\/10.3389\/fnins.2019.00604","journal-title":"Front Neurosci"},{"key":"3546_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","volume":"40","author":"DC Maddison","year":"2015","unstructured":"Maddison DC, Giorgini F (2015) The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol 40:134\u2013141. https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.002","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"3546_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"24","key":"3546_CR6","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.3390\/ijms21249338","volume":"21","author":"N T\u00f6r\u00f6k","year":"2020","unstructured":"T\u00f6r\u00f6k N, Tanaka M, V\u00e9csei L (2020) Searching for peripheral biomarkers in neurodegenerative diseases: the tryptophan-kynurenine metabolic pathway. Int J Mol Sci 21(24):9338. https:\/\/doi.org\/10.3390\/ijms21249338","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3546_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2174\/1570159X18666200128125641","volume":"18","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Mehta V, Singh TG (2020) Alzheimer\u2019s disorder: epigenetic connection and associated risk factors. Curr Neuropharm 18(8):740\u2013753. https:\/\/doi.org\/10.2174\/1570159X18666200128125641","journal-title":"Curr Neuropharm"},{"issue":"5","key":"3546_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2174\/1389450120666191017114735","volume":"21","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG (2020) Navigating Alzheimer\u2019s disease via chronic stress: the role of glucocorticoids. Curr Drug Target 21(5):433\u2013444. https:\/\/doi.org\/10.2174\/1389450120666191017114735","journal-title":"Curr Drug Target"},{"key":"3546_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110373","volume":"129","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kaur A, Singh TG (2020) Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease. Biomed Pharmacother 129:110373. https:\/\/doi.org\/10.1016\/j.biopha.2020.110373","journal-title":"Biomed Pharmacother"},{"key":"3546_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118401","volume":"262","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG (2020) Insulin resistance and bioenergetic manifestations: targets and approaches in Alzheimer\u2019s disease. Life Sci 262:118401. https:\/\/doi.org\/10.1016\/j.lfs.2020.118401","journal-title":"Life Sci"},{"issue":"6","key":"3546_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/187152707783399229","volume":"6","author":"V P\u00e9rez-De La Cruz","year":"2007","unstructured":"P\u00e9rez-De La Cruz V, K\u00f6nigsberg M, Santamar\u00eda A (2007) Kynurenine pathway and disease: an overview. CNS Neurol Disord Drug Targets 6(6):398\u2013410. https:\/\/doi.org\/10.2174\/187152707783399229","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3546_CR12","doi-asserted-by":"publisher","first-page":"8952520","DOI":"10.1155\/2016\/8952520","volume":"2016","author":"L Palego","year":"2016","unstructured":"Palego L, Betti L, Rossi A et al (2016) Tryptophan biochemistry: structural, nutritional, metabolic, and medical aspects in humans. J Amino Acids 2016:8952520. https:\/\/doi.org\/10.1155\/2016\/8952520","journal-title":"J Amino Acids"},{"issue":"14","key":"3546_CR13","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.2174\/1567205018666210218152253","volume":"17","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG (2020) CREB: a multifaceted target for Alzheimer\u2019s disease. Curr Alzheimer Res 17(14):1280\u20131293. https:\/\/doi.org\/10.2174\/1567205018666210218152253","journal-title":"Curr Alzheimer Res"},{"key":"3546_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-016-0590-y","volume":"13","author":"JM Parrott","year":"2016","unstructured":"Parrott JM, Redus L, O\u2019Connor JC (2016) Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge. J Neuroinflamm 13:124. https:\/\/doi.org\/10.1186\/s12974-016-0590-y","journal-title":"J Neuroinflamm"},{"issue":"6","key":"3546_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1573399815666191111152248","volume":"16","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG (2020) Chronic stress and diabetes mellitus: interwoven pathologies. Curr Diabetes Rev 16(6):546\u2013556. https:\/\/doi.org\/10.2174\/1573399815666191111152248","journal-title":"Curr Diabetes Rev"},{"key":"3546_CR16","doi-asserted-by":"publisher","DOI":"10.32527\/2019\/101415","author":"AAB Badawy","year":"2019","unstructured":"Badawy AAB (2019) Tryptophan metabolism: a versatile area providing multiple targets for pharmacological intervention. Egypt J Basic Clin Pharmacol. https:\/\/doi.org\/10.32527\/2019\/101415","journal-title":"Egypt J Basic Clin Pharmacol"},{"key":"3546_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbi.2018.10.003","volume":"75","author":"SEH Solvang","year":"2019","unstructured":"Solvang SEH, Nordrehaug JE, Tell GS et al (2019) The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study. Brain Behav Immun 75:155\u2013162. https:\/\/doi.org\/10.1016\/j.bbi.2018.10.003","journal-title":"Brain Behav Immun"},{"issue":"12","key":"3546_CR18","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.bbi.2018.10.003","volume":"288","author":"CG Lyketsos","year":"2002","unstructured":"Lyketsos CG, Lopez O, Jones B et al (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288(12):1475\u20131483. https:\/\/doi.org\/10.1016\/j.bbi.2018.10.003","journal-title":"JAMA"},{"issue":"6","key":"3546_CR19","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI et al (1991) Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56(6):2007\u20132017. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb03460.x","journal-title":"J Neurochem"},{"key":"3546_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fendo.2019.00158","volume":"10","author":"E H\u00f6glund","year":"2019","unstructured":"H\u00f6glund E, \u00d8verli \u00d8, Winberg S (2019) Tryptophan metabolic pathways and brain serotonergic activity: a comparative review. Front Endocrinol 10:158. https:\/\/doi.org\/10.3389\/fendo.2019.00158","journal-title":"Front Endocrinol"},{"issue":"7","key":"3546_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14737175.2015.1049999","volume":"15","author":"I Davis","year":"2015","unstructured":"Davis I, Liu A (2015) What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics? Expert Rev Neurother 15(7):719\u2013721. https:\/\/doi.org\/10.1586\/14737175.2015.1049999","journal-title":"Expert Rev Neurother"},{"key":"3546_CR22","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3390\/ijms21072431","volume":"21","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Toldi J, V\u00e9csei L (2020) Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines. Int J Mol Sci 21:2431. https:\/\/doi.org\/10.3390\/ijms21072431","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3546_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1517\/14728220802665734","volume":"13","author":"G Costantino","year":"2009","unstructured":"Costantino G (2009) New promises for manipulation of kynurenine pathway in cancer and neurological diseases. Expert Opin Ther Targets 13(2):247\u2013258. https:\/\/doi.org\/10.1517\/14728220802665734","journal-title":"Expert Opin Ther Targets"},{"key":"3546_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3389\/fimmu.2017.01374","volume":"8","author":"AP Van der Leek","year":"2017","unstructured":"Van der Leek AP, Yanishevsky Y, Kozyrskyj AL (2017) The kynurenine pathway as a novel link between allergy and the gut microbiome. Front Immunol 8:1374. https:\/\/doi.org\/10.3389\/fimmu.2017.01374","journal-title":"Front Immunol"},{"issue":"2","key":"3546_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12035-013-8497-4","volume":"48","author":"G Oxenkrug","year":"2013","unstructured":"Oxenkrug G (2013) Insulin resistance and dysregulation of tryptophan\u2013kynurenine and kynurenine\u2013nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol 48(2):294\u2013301. https:\/\/doi.org\/10.1007\/s12035-013-8497-4","journal-title":"Mol Neurobiol"},{"issue":"5","key":"3546_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/s1471-4906(03)00072-3","volume":"24","author":"U Grohmann","year":"2003","unstructured":"Grohmann U, Fallarino F, Puccetti P (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24(5):242\u2013248. https:\/\/doi.org\/10.1016\/s1471-4906(03)00072-3","journal-title":"Trends Immunol"},{"issue":"4","key":"3546_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","volume":"196","author":"G Frumento","year":"2002","unstructured":"Frumento G, Rotondo R, Tonetti M (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J Exp Med 196(4):459\u2013468. https:\/\/doi.org\/10.1084\/jem.20020121","journal-title":"J Exp Med"},{"issue":"1","key":"3546_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1673-5374.198971","volume":"12","author":"N Braidy","year":"2017","unstructured":"Braidy N, Grant R (2017) Kynurenine pathway metabolism and neuroinflammatory disease. Neural Regen Res 12(1):39. https:\/\/doi.org\/10.4103\/1673-5374.198971","journal-title":"Neural Regen Res"},{"key":"3546_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/1178646917691938","author":"AA Badawy","year":"2017","unstructured":"Badawy AA (2017) Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res. https:\/\/doi.org\/10.1177\/1178646917691938","journal-title":"Int J Tryptophan Res"},{"issue":"2","key":"3546_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/JAD-170485","volume":"60","author":"LM Giil","year":"2017","unstructured":"Giil LM, Midttun \u00d8, Refsum H et al (2017) Kynurenine pathway metabolites in Alzheimer\u2019s disease. J Alzheimers Dis 60(2):495\u2013504. https:\/\/doi.org\/10.3233\/JAD-170485","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3546_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s007020050029","volume":"107","author":"B Widner","year":"2000","unstructured":"Widner B, Leblhuber F, Walli J et al (2000) Tryptophan degradation and immune activation in Alzheimer\u2019s disease. J Neural Transm Suppl 107(3):343\u2013353. https:\/\/doi.org\/10.1007\/s007020050029","journal-title":"J Neural Transm Suppl"},{"issue":"2","key":"3546_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s007020050149","volume":"106","author":"H Baran","year":"1999","unstructured":"Baran H, Jellinger K, Deecke L (1999) Kynurenine metabolism in Alzheimer\u2019s disease. J Neural Transm Suppl 106(2):165\u2013181. https:\/\/doi.org\/10.1007\/s007020050149","journal-title":"J Neural Transm Suppl"},{"issue":"3","key":"3546_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3390\/molecules25030564","volume":"25","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Boh\u00e1r Z, V\u00e9csei L (2020) Are kynurenines accomplices or principal villains in dementia? Maintenance of kynurenine metabolism. Molecules 25(3):564. https:\/\/doi.org\/10.3390\/molecules25030564","journal-title":"Molecules"},{"issue":"4","key":"3546_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/135100002125000550","volume":"7","author":"GJ Guillemin","year":"2002","unstructured":"Guillemin GJ, Brew BJ (2002) Implications of the kynurenine pathway and quinolinic acid in Alzheimer\u2019s disease. Redox Rep 7(4):199\u2013206. https:\/\/doi.org\/10.1179\/135100002125000550","journal-title":"Redox Rep"},{"key":"3546_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9794","author":"I Cervenka","year":"2017","unstructured":"Cervenka I, Agudelo LZ, Ruas JL (2017) Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health. Science. https:\/\/doi.org\/10.1126\/science.aaf9794","journal-title":"Science"},{"issue":"12","key":"3546_CR36","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3390\/ijms19123917","volume":"19","author":"V Chobot","year":"2018","unstructured":"Chobot V, Hadacek F, Bachmann G et al (2018) Antioxidant properties and the formation of iron coordination complexes of 8-hydroxyquinoline. Int J Mol Sci 19(12):3917. https:\/\/doi.org\/10.3390\/ijms19123917","journal-title":"Int J Mol Sci"},{"key":"3546_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Smith DG, Smythe GA et al (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105\u2013112. https:\/\/doi.org\/10.1007\/978-1-4615-0135-0_12","journal-title":"Adv Exp Med Biol"},{"issue":"Pt B","key":"3546_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","volume":"112","author":"K O'Farrell","year":"2017","unstructured":"O\u2019Farrell K, Harkin A (2017) Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders. Neuropharmacology 112(Pt B):307\u2013323. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.12.004","journal-title":"Neuropharmacology"},{"issue":"1","key":"3546_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biomedicines9010009","volume":"9","author":"A Gyawali","year":"2021","unstructured":"Gyawali A, Kang YS (2021) Pretreatment effect of inflammatory stimuli and characteristics of tryptophan transport on brain capillary endothelial (TR-BBB) and motor neuron like (NSC-34) cell lines. Biomedicines 9(1):9. https:\/\/doi.org\/10.3390\/biomedicines9010009","journal-title":"Biomedicines"},{"key":"3546_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","volume":"112","author":"MD Lovelace","year":"2017","unstructured":"Lovelace MD, Varney B, Sundaram G et al (2017) Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacol 112:373\u2013388. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.024","journal-title":"Neuropharmacol"},{"issue":"1","key":"3546_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1567-4","volume":"16","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee P, Zetterberg H, Goozee K et al (2019) Plasma neurofilament light chain and amyloid-\u03b2 are associated with the kynurenine pathway metabolites in pre-clinical Alzheimer\u2019s disease. J Neuroinflamm 16(1):1\u201312. https:\/\/doi.org\/10.1186\/s12974-019-1567-4","journal-title":"J Neuroinflamm"},{"key":"3546_CR42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3389\/fnins.2019.01013","volume":"13","author":"VX Tan","year":"2019","unstructured":"Tan VX, Guillemin GJ (2019) Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis. Front Neurosci 13:1013. https:\/\/doi.org\/10.3389\/fnins.2019.01013","journal-title":"Front Neurosci"},{"issue":"12","key":"3546_CR43","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.jalz.2017.04.009","volume":"13","author":"V Chouraki","year":"2017","unstructured":"Chouraki V, Preis SR, Yang Q (2017) Association of amine biomarkers with incident dementia and Alzheimer\u2019s disease in the Framingham Study. Alzheimer Dement 13(12):1327\u20131336. https:\/\/doi.org\/10.1016\/j.jalz.2017.04.009","journal-title":"Alzheimer Dement"},{"issue":"2","key":"3546_CR44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuint.2006.08.012","volume":"50","author":"Z Hartai","year":"2007","unstructured":"Hartai Z, Juh\u00e1sz A, Riman\u00f3czy \u00c1 et al (2007) Decreased serum and red blood cell kynurenic acid levels in Alzheimer\u2019s disease. Neurochem Int 50(2):308\u2013313. https:\/\/doi.org\/10.1016\/j.neuint.2006.08.012","journal-title":"Neurochem Int"},{"issue":"2","key":"3546_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj E, Pawlak K, Bien B et al (2010) Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv Med Sci 55(2):204\u2013211. https:\/\/doi.org\/10.2478\/v10039-010-0023-6","journal-title":"Adv Med Sci"},{"issue":"5","key":"3546_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1440-1819.2008.01854.x","volume":"62","author":"AR Van Gool","year":"2008","unstructured":"Van Gool AR, Verkerk R, Fekkes D et al (2008) Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-\u03b1: course and relationship with psychiatric status: Interferon-\u03b1 and kynurenine metabolites. Psychiatry Clin Neurosci 62(5):597\u2013602. https:\/\/doi.org\/10.1111\/j.1440-1819.2008.01854.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"3546_CR47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00726-012-1330-y","volume":"45","author":"JD Fernstrom","year":"2013","unstructured":"Fernstrom JD (2013) Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino Acids 45(3):419\u2013430. https:\/\/doi.org\/10.1007\/s00726-012-1330-y","journal-title":"Amino Acids"},{"key":"3546_CR48","doi-asserted-by":"publisher","first-page":"117864691987788","DOI":"10.1177\/1178646919877883","volume":"12","author":"SE Hafstad Solvang","year":"2019","unstructured":"Hafstad Solvang SE, Nordrehaug JE, Aarsland D et al (2019) Kynurenines, neuropsychiatric symptoms, and cognitive prognosis in patients with mild dementia. Int J Tryptophan Res 12:1178646919877883. https:\/\/doi.org\/10.1177\/1178646919877883","journal-title":"Int J Tryptophan Res"},{"key":"3546_CR49","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","volume":"10","author":"FJ Sorgdrager","year":"2019","unstructured":"Sorgdrager FJ, Naud\u00e9 PJ, Kema IP (2019) Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front Immunol 10:2565. https:\/\/doi.org\/10.3389\/fimmu.2019.02565","journal-title":"Front Immunol"},{"key":"3546_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mito.2021.04.004","volume":"59","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Mehta V (2021) Stressed mitochondria: a target to intrude Alzheimer\u2019s disease. Mitochondrion 59:48\u201357. https:\/\/doi.org\/10.1016\/j.mito.2021.04.004","journal-title":"Mitochondrion"},{"issue":"1","key":"3546_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25968-7","volume":"8","author":"P Chatterjee","year":"2018","unstructured":"Chatterjee P, Goozee K, Lim CK et al (2018) Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-\u03b2 load: a pilot study. Sci Rep 8(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-018-25968-7","journal-title":"Sci Rep"},{"issue":"3","key":"3546_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1567202054368326","volume":"2","author":"H N\u00e9meth","year":"2005","unstructured":"N\u00e9meth H, Toldi J, V\u00e9csei L (2005) Role of kynurenines in the central and peripherial nervous systems. Curr Neurovasc Res 2(3):249\u2013260. https:\/\/doi.org\/10.2174\/1567202054368326","journal-title":"Curr Neurovasc Res"},{"issue":"4","key":"3546_CR53","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1046\/j.1471-4159.1997.69041629.x","volume":"69","author":"YM Bordelon","year":"1997","unstructured":"Bordelon YM, Chesselet MF, Nelson D et al (1997) Energetic dysfunction in quinolinic acid lesioned rat striatum. J Neurochem 69(4):1629\u20131639. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.69041629.x","journal-title":"J Neurochem"},{"issue":"4","key":"3546_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00002030-199804000-00003","volume":"12","author":"SJ Kerr","year":"1998","unstructured":"Kerr SJ, Armati PJ, Guillemin GJ et al (1998) Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 12(4):355\u2013363. https:\/\/doi.org\/10.1097\/00002030-199804000-00003","journal-title":"AIDS"},{"issue":"4","key":"3546_CR55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","volume":"31","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Brew BJ, Noonan CE (2005) Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus. Neuropathol Appl Neurobiol 31(4):395\u2013404. https:\/\/doi.org\/10.1111\/j.1365-2990.2005.00655.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"3546_CR56","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11064-021-03274-5","volume":"46","author":"T Singh","year":"2021","unstructured":"Singh T, Goel RK (2021) Epilepsy associated depression: an update on current scenario, suggested mechanisms, and opportunities. Neurochem Res 46(6):1305\u20131321. https:\/\/doi.org\/10.1007\/s11064-021-03274-5","journal-title":"Neurochem Res"},{"key":"3546_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.yebeh.2017.04.004","volume":"72","author":"N Kaur","year":"2017","unstructured":"Kaur N, Singh T, Kumar S, Goel RK (2017) Neurochemical evidence based suggested therapy for safe management of epileptogenesis. Epilepsy Behav 72:8\u201316. https:\/\/doi.org\/10.1016\/j.yebeh.2017.04.004","journal-title":"Epilepsy Behav"},{"key":"3546_CR58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","volume":"92","author":"T Singh","year":"2017","unstructured":"Singh T, Bagga N, Kaur A et al (2017) Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. Biomed Pharmacother 92:720\u2013725. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.085","journal-title":"Biomed Pharmacother"},{"key":"3546_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2016.10.007","volume":"66","author":"T Singh","year":"2017","unstructured":"Singh T, Goel RK (2017) Managing epilepsy-associated depression: serotonin enhancers or serotonin producers? Epilepsy Behav 66:93\u201399. https:\/\/doi.org\/10.1016\/j.yebeh.2016.10.007","journal-title":"Epilepsy Behav"},{"issue":"22","key":"3546_CR60","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1111\/j.1742-4658.2011.08366.x","volume":"278","author":"N Braidy","year":"2011","unstructured":"Braidy N, Guillemin GJ, Mansour H et al (2011) Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. FEBS J 278(22):4425\u20134434. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08366.x","journal-title":"FEBS J"},{"key":"3546_CR61","first-page":"53","volume":"19","author":"WO Whetsell Jr","year":"1983","unstructured":"Whetsell WO Jr, Schwarcz R (1983) The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxicity and its antagonism: studies on kainic acid, quinolinic acid and (-) 2-amino-7-phosphonoheptanoic acid. J Neural Transm Suppl 19:53\u201363","journal-title":"J Neural Transm Suppl"},{"issue":"7","key":"3546_CR62","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1515\/CCLM.2003.129","volume":"41","author":"TW Stone","year":"2003","unstructured":"Stone TW, Mackay GM, Forrest CM et al (2003) Tryptophan metabolites and brain disorders. Clin Chem Lab Med 41(7):852\u2013859. https:\/\/doi.org\/10.1515\/CCLM.2003.129","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"3546_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006344","volume":"4","author":"A Rahman","year":"2009","unstructured":"Rahman A, Ting K, Cullen KM et al (2009) The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS ONE 4(7):e6344. https:\/\/doi.org\/10.1371\/journal.pone.0006344","journal-title":"PLoS ONE"},{"issue":"4","key":"3546_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0197-4580(85)90012-0","volume":"6","author":"RJ Boegman","year":"1985","unstructured":"Boegman RJ, El-Defrawy SR, Jhamandas K et al (1985) Quinolinic acid neurotoxicity in the nucleus basalis antagonized by kynurenic acid. Neurobiol Aging 6(4):331\u2013336. https:\/\/doi.org\/10.1016\/0197-4580(85)90012-0","journal-title":"Neurobiol Aging"},{"issue":"4","key":"3546_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0028-3908(96)00005-6","volume":"35","author":"M Misztal","year":"1996","unstructured":"Misztal M, Skangiel-Kramska J, Niewiadomska G et al (1996) Subchronic intraventricular infusion of quinolinic acid produces working memory impairment\u2014a model of progressive excitotoxicity. Neuropharmacology 35(4):449\u2013458. https:\/\/doi.org\/10.1016\/0028-3908(96)00005-6","journal-title":"Neuropharmacology"},{"issue":"4","key":"3546_CR66","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","volume":"263","author":"MJ Schwarz","year":"2013","unstructured":"Schwarz MJ, Guillemin GJ, Teipel SJ (2013) Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls. Eur Arch Psychiatry Clin Neurosci 263(4):345\u2013352. https:\/\/doi.org\/10.1007\/s00406-012-0384-x","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3546_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101800","volume":"190","author":"M Maitre","year":"2020","unstructured":"Maitre M, Klein C, Patte-Mensah C et al (2020) Tryptophan metabolites modify brain A\u03b2 peptide degradation: a role in Alzheimer\u2019s disease? Prog Neurobiol 190:101800. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101800","journal-title":"Prog Neurobiol"},{"key":"3546_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00388","author":"YS Huang","year":"2020","unstructured":"Huang YS, Ogbechi J, Clanchy FI et al (2020) IDO and kynurenine metabolites in peripheral and CNS disorders. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00388","journal-title":"Front Immunol"},{"key":"3546_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1749-6632.1990.tb28059.x","volume":"85","author":"RJ Boegman","year":"1990","unstructured":"Boegman RJ, Jhamandas K, Beninger RJ (1990) Neurotoxicity of tryptophan metabolites. Ann N Y Acad Sci 85:261\u2013273. https:\/\/doi.org\/10.1111\/j.1749-6632.1990.tb28059.x","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"3546_CR70","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1212\/wnl.40.4.691","volume":"40","author":"A Freese","year":"1990","unstructured":"Freese A, Swartz KJ, During MJ et al (1990) Kynurenine metabolites of tryptophan: implications for neurologic diseases. Neurology 40(4):691\u2013691. https:\/\/doi.org\/10.1212\/wnl.40.4.691","journal-title":"Neurology"},{"issue":"1","key":"3546_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","volume":"197","author":"MT Sapko","year":"2006","unstructured":"Sapko MT, Guidetti P, Yu P et al (2006) Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington\u2019s disease. Exp Neurol 197(1):31\u201340. https:\/\/doi.org\/10.1016\/j.expneurol.2005.07.004","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"3546_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","volume":"283","author":"E Vamos","year":"2009","unstructured":"Vamos E, Pardutz A, Klivenyi P et al (2009) The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 283(1\u20132):21\u201327. https:\/\/doi.org\/10.1016\/j.jns.2009.02.326","journal-title":"J Neurol Sci"},{"issue":"4","key":"3546_CR73","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/biom10040571","volume":"10","author":"M Gonz\u00e1lez-S\u00e1nchez","year":"2020","unstructured":"Gonz\u00e1lez-S\u00e1nchez M, Jim\u00e9nez J, Narv\u00e1ez A et al (2020) Kynurenic acid levels are increased in the CSF of Alzheimer\u2019s disease patients. Biomolecules 10(4):571. https:\/\/doi.org\/10.3390\/biom10040571","journal-title":"Biomolecules"},{"key":"3546_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/646909","volume":"2014","author":"J Reyes Ocampo","year":"2014","unstructured":"Reyes Ocampo J, Lugo Huitr\u00f3n R, Gonz\u00e1lez-Esquivel D et al (2014) Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev 2014:646909. https:\/\/doi.org\/10.1155\/2014\/646909","journal-title":"Oxid Med Cell Longev"},{"key":"3546_CR75","doi-asserted-by":"publisher","DOI":"10.1177\/1178646920970902","author":"A Bhat","year":"2020","unstructured":"Bhat A, Pires AS, Tan V et al (2020) Effects of sleep deprivation on the tryptophan metabolism. Int J Tryptophan Res. https:\/\/doi.org\/10.1177\/1178646920970902","journal-title":"Int J Tryptophan Res"},{"key":"3546_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmolb.2019.00007","volume":"6","author":"F Rossi","year":"2019","unstructured":"Rossi F, Miggiano R, Ferraris DM et al (2019) The synthesis of kynurenic acid in mammals: an updated kynurenine aminotransferase structural KATalogue. Front Mol Biosci 6:7. https:\/\/doi.org\/10.3389\/fmolb.2019.00007","journal-title":"Front Mol Biosci"},{"issue":"10","key":"3546_CR77","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/antiox8100476","volume":"8","author":"L Kubicova","year":"2019","unstructured":"Kubicova L, Hadacek F, Bachmann G et al (2019) Coordination complex formation and redox properties of kynurenic and xanthurenic acid can affect brain tissue homeodynamics. Antioxidants 8(10):476. https:\/\/doi.org\/10.3390\/antiox8100476","journal-title":"Antioxidants"},{"key":"3546_CR78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4137\/ijtr.s2469","volume":"2","author":"RS Grant","year":"2009","unstructured":"Grant RS, Coggan SE, Smythe GA (2009) The physiological action of picolinic acid in the human brain. Int J Tryptophan Res 2:71\u201379. https:\/\/doi.org\/10.4137\/ijtr.s2469","journal-title":"Int J Tryptophan Res"},{"issue":"3","key":"3546_CR79","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1042\/bj2510893","volume":"251","author":"H Iwahashi","year":"1988","unstructured":"Iwahashi H, Ishii T, Sugata R et al (1988) Superoxide dismutase enhances the formation of hydroxyl radicals in the reaction of 3-hydroxyanthranilic acid with molecular oxygen. Biochem J 251(3):893\u2013899. https:\/\/doi.org\/10.1042\/bj2510893","journal-title":"Biochem J"},{"issue":"7","key":"3546_CR80","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1073\/pnas.87.7.2506","volume":"87","author":"S Christen","year":"1990","unstructured":"Christen S, Peterhans E, Stocker R (1990) Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci 87(7):2506\u20132510. https:\/\/doi.org\/10.1073\/pnas.87.7.2506","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3546_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40495-019-00208-2","volume":"6","author":"A Tutakhail","year":"2020","unstructured":"Tutakhail A, Boulet L, Khabil S et al (2020) Neuropathology of kynurenine pathway of tryptophan metabolism. Curr Pharmacol Rep 6(1):8\u201323. https:\/\/doi.org\/10.1007\/s40495-019-00208-2","journal-title":"Curr Pharmacol Rep"},{"issue":"2","key":"3546_CR82","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1254\/jjp.71.183","volume":"71","author":"Y Nakagami","year":"1996","unstructured":"Nakagami Y, Saito H, Katsuki H (1996) 3-Hydroxykynurenine toxicity on the rat striatum in vivo. Jpn J Pharmacol 71(2):183\u2013186. https:\/\/doi.org\/10.1254\/jjp.71.183","journal-title":"Jpn J Pharmacol"},{"issue":"11","key":"3546_CR83","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","volume":"11","author":"P Guidetti","year":"1999","unstructured":"Guidetti P, Schwarcz R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11(11):3857\u20133863. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00806.x","journal-title":"Eur J Neurosci"},{"issue":"6","key":"3546_CR84","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling D, Huang SY, Sathyasaikumar KV (2011) Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145(6):863\u2013874. https:\/\/doi.org\/10.1016\/j.cell.2011.05.020","journal-title":"Cell"},{"issue":"17","key":"3546_CR85","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.3390\/ijms21176045","volume":"21","author":"F Jovanovic","year":"2020","unstructured":"Jovanovic F, Candido KD, Knezevic NN (2020) The role of the kynurenine signaling pathway in different chronic pain conditions and potential use of therapeutic agents. Int J Mol Sci 21(17):6045. https:\/\/doi.org\/10.3390\/ijms21176045","journal-title":"Int J Mol Sci"},{"key":"3546_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108702","volume":"697","author":"S Zhang","year":"2020","unstructured":"Zhang S, Collier ME, Heyes DJ et al (2020) Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases. Arch Biochem Biophys 697:108702. https:\/\/doi.org\/10.1016\/j.abb.2020.108702","journal-title":"Arch Biochem Biophys"},{"key":"3546_CR87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fnins.2021.661198","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Bao G, Liu D et al (2021) The association between folate and Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Neurosci 15:385. https:\/\/doi.org\/10.3389\/fnins.2021.661198","journal-title":"Front Neurosci"},{"key":"3546_CR88","doi-asserted-by":"publisher","DOI":"10.1177\/1178646920972657","author":"FJH Sorgdrager","year":"2020","unstructured":"Sorgdrager FJH, van Der Ley CP, van Faassen M et al (2020) The effect of tryptophan 2, 3-dioxygenase inhibition on kynurenine metabolism and cognitive function in the APP23 mouse model of alzheimer\u2019s disease. Int J Tryptophan Res. https:\/\/doi.org\/10.1177\/1178646920972657","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"3546_CR89","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/JAD-140414","volume":"43","author":"D Yu","year":"2015","unstructured":"Yu D, Tao BB, Yang YY et al (2015) The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer\u2019s disease. J Alzheimer Dis 43(1):291\u2013302. https:\/\/doi.org\/10.3233\/JAD-140414","journal-title":"J Alzheimer Dis"},{"issue":"4","key":"3546_CR90","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1179\/174329210X12650506623645","volume":"15","author":"DJ Bonda","year":"2010","unstructured":"Bonda DJ, Mailankot M, Stone JG et al (2010) Indoleamine 2, 3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer\u2019s disease. Redox Rep 15(4):161\u2013168. https:\/\/doi.org\/10.1179\/174329210X12650506623645","journal-title":"Redox Rep"},{"issue":"2","key":"3546_CR91","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/gps.3802","volume":"28","author":"DC Parker","year":"2013","unstructured":"Parker DC, Mielke MM, Yu Q (2013) Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer\u2019s disease. Int J Geriatr Psychiatry 28(2):149\u2013154. https:\/\/doi.org\/10.1002\/gps.3802","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"3546_CR92","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jphs.2014.11.006","volume":"127","author":"TY Yu","year":"2015","unstructured":"Yu TY, Pang WJ, Yang GS (2015) 3, 3\u2032-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice. J Pharmacol Sci 127(1):75\u201382. https:\/\/doi.org\/10.1016\/j.jphs.2014.11.006","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"3546_CR93","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.clinbiochem.2004.02.007","volume":"37","author":"B Frick","year":"2004","unstructured":"Frick B, Schroecksnadel K, Neurauter G et al (2004) Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem 37(8):684\u2013687. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.02.007","journal-title":"Clin Biochem"},{"issue":"2","key":"3546_CR94","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/10253890701685908","volume":"11","author":"H Miura","year":"2008","unstructured":"Miura H, Ozaki N, Shirokawa T et al (2008) Changes in brain tryptophan metabolism elicited by ageing, social environment, and psychological stress in mice. Stress 11(2):160\u2013169. https:\/\/doi.org\/10.1080\/10253890701685908","journal-title":"Stress"},{"key":"3546_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4137\/IJTR.S7052","volume":"4","author":"N Braidy","year":"2011","unstructured":"Braidy N, Guillemin GJ, Grant R (2011) Effects of kynurenine pathway inhibition on NAD+ metabolism and cell viability in human primary astrocytes and neurons. Int J Tryptophan Res 4:29\u201337. https:\/\/doi.org\/10.4137\/IJTR.S7052","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"3546_CR96","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1196\/annals.1403.003","volume":"1122","author":"GF Oxenkrug","year":"2007","unstructured":"Oxenkrug GF (2007) Genetic and hormonal regulation of tryptophan-kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 1122(1):35\u201349. https:\/\/doi.org\/10.1196\/annals.1403.003","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3546_CR97","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000086295","volume":"14","author":"B Kepplinger","year":"2005","unstructured":"Kepplinger B, Baran H, Kainz A et al (2005) Age-related increase of kynurenic acid in human cerebrospinal fluid\u2013IgG and \u03b22-microglobulin changes. Neurosignals 14(3):126\u2013135. https:\/\/doi.org\/10.1159\/000086295","journal-title":"Neurosignals"},{"issue":"5","key":"3546_CR98","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115(5):1249\u20131273. https:\/\/doi.org\/10.1093\/brain\/115.5.1249","journal-title":"Brain"},{"issue":"8","key":"3546_CR99","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1582-4934.2010.01123.x","volume":"14","author":"TK Zsigmond","year":"2010","unstructured":"Zsigmond TK, Toldi J, V\u00e9csei L (2010) Kynurenines, neurodegeneration and Alzheimer\u2019s disease. J Cell Mol Med 14(8):2045\u20132054. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01123.x","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3546_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13510002.2017.1343223","volume":"23","author":"K Parasram","year":"2018","unstructured":"Parasram K (2018) Phytochemical treatments target kynurenine pathway induced oxidative stress. Redox Rep 23(1):25\u201328. https:\/\/doi.org\/10.1080\/13510002.2017.1343223","journal-title":"Redox Rep"},{"key":"3546_CR101","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","volume":"5","author":"N Xie","year":"2020","unstructured":"Xie N, Zhang L, Gao W et al (2020) NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Sig Transduct Target Ther 5:227. https:\/\/doi.org\/10.1038\/s41392-020-00311-7","journal-title":"Sig Transduct Target Ther"},{"key":"3546_CR102","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5522981","author":"OS Adeyemi","year":"2021","unstructured":"Adeyemi OS, Awakan OJ, Afolabi LB et al (2021) Hypoxia and the kynurenine pathway: implications and therapeutic prospects in Alzheimer\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2021\/5522981","journal-title":"Oxid Med Cell Longev"},{"issue":"17","key":"3546_CR103","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2174\/1568026616666160204121431","volume":"16","author":"N Braidy","year":"2016","unstructured":"Braidy N, Jugder BE, Poljak A et al (2016) Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer\u2019s disease. Curr Top Med Chem 16(17):1951\u20131960. https:\/\/doi.org\/10.2174\/1568026616666160204121431","journal-title":"Curr Top Med Chem"},{"key":"3546_CR104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2014.00012","volume":"8","author":"BM Campbell","year":"2014","unstructured":"Campbell BM, Charych E, Lee AW (2014) Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci 8:12. https:\/\/doi.org\/10.3389\/fnins.2014.00012","journal-title":"Front Neurosci"},{"key":"3546_CR105","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112:237\u2013247. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003","journal-title":"Neuropharmacology"},{"issue":"7","key":"3546_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042357","volume":"7","author":"H Massudi","year":"2012","unstructured":"Massudi H, Grant R, Braidy N et al (2012) Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE 7(7):e42357. https:\/\/doi.org\/10.1371\/journal.pone.0042357","journal-title":"PLoS ONE"},{"key":"3546_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118975","volume":"267","author":"K Thapa","year":"2020","unstructured":"Thapa K, Khan H, Sharma U et al (2020) Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases. Life Sci 267:118975. https:\/\/doi.org\/10.1016\/j.lfs.2020.118975","journal-title":"Life Sci"},{"key":"3546_CR108","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fncel.2014.00112","volume":"8","author":"I Morales","year":"2014","unstructured":"Morales I, Guzm\u00e1n-Mart\u00ednez L, Cerda-Troncoso C et al (2014) Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112. https:\/\/doi.org\/10.3389\/fncel.2014.00112","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"3546_CR109","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s11064-021-03418-7","volume":"46","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Singh S et al (2021) Apoptotic pathways and Alzheimer\u2019s disease: probing therapeutic potential. Neurochem Res 46(12):3103\u20133122. https:\/\/doi.org\/10.1007\/s11064-021-03418-7","journal-title":"Neurochem Res"},{"key":"3546_CR110","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbi.2021.03.019","volume":"95","author":"AA Willette","year":"2021","unstructured":"Willette AA, Pappas C, Hoth N et al (2021) Inflammation, negative affect, and amyloid burden in Alzheimer\u2019s disease: insights from the kynurenine pathway. Brain Behav Immun 95:216\u2013225. https:\/\/doi.org\/10.1016\/j.bbi.2021.03.019","journal-title":"Brain Behav Immun"},{"issue":"13","key":"3546_CR111","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2174\/1389450121666200727104728","volume":"21","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG, Singh S (2020) Cyclic nucleotides signaling and phosphodiesterase inhibition: defying Alzheimer\u2019s disease. Curr Drug Targets 21(13):1371\u20131384. https:\/\/doi.org\/10.2174\/1389450121666200727104728","journal-title":"Curr Drug Targets"},{"issue":"6","key":"3546_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038522","volume":"7","author":"Q Wang","year":"2012","unstructured":"Wang Q, Chen J, Wang Y et al (2012) Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway. PLoS ONE 7(6):e38522. https:\/\/doi.org\/10.1371\/journal.pone.0038522","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"3546_CR113","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00335-013-9488-5","volume":"25","author":"RD Moloney","year":"2014","unstructured":"Moloney RD, Desbonnet L, Clarke G et al (2014) The microbiome: stress, health and disease. Mamm Genome 25(1\u20132):49\u201374. https:\/\/doi.org\/10.1007\/s00335-013-9488-5","journal-title":"Mamm Genome"},{"issue":"2","key":"3546_CR114","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12640-019-00057-3","volume":"36","author":"ML Garcez","year":"2019","unstructured":"Garcez ML, Jacobs KR, Guillemin GJ (2019) Microbiota alterations in Alzheimer\u2019s disease: involvement of the kynurenine pathway and inflammation. Neurotox Res 36(2):424\u2013436. https:\/\/doi.org\/10.1007\/s12640-019-00057-3","journal-title":"Neurotox Res"},{"issue":"5","key":"3546_CR115","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/biom11050678","volume":"11","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Garg N et al (2021) Dysbiosis and Alzheimer\u2019s disease: a role for chronic stress? Biomolecules 11(5):678. https:\/\/doi.org\/10.3390\/biom11050678","journal-title":"Biomolecules"},{"issue":"39","key":"3546_CR116","doi-asserted-by":"publisher","first-page":"14105","DOI":"10.3748\/wjg.v20.i39.14105","volume":"20","author":"PJ Kennedy","year":"2014","unstructured":"Kennedy PJ, Cryan JF, Dinan TG (2014) Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol 20(39):14105. https:\/\/doi.org\/10.3748\/wjg.v20.i39.14105","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3546_CR117","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.33263\/BRIAC121.13041323","volume":"12","author":"N Garg","year":"2022","unstructured":"Garg N, Singh TG, Khan H et al (2022) Mechanistic interventions of selected Ocimum species in management of diabetes, obesity and liver disorders: transformative developments from pre-clinical to clinical approaches. Biointerface Res Appl Chem 12(1):1304\u20131323. https:\/\/doi.org\/10.33263\/BRIAC121.13041323","journal-title":"Biointerface Res Appl Chem"},{"issue":"4","key":"3546_CR118","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jcmgh.2019.01.004","volume":"7","author":"YH Kwon","year":"2019","unstructured":"Kwon YH, Wang H, Denou E et al (2019) Modulation of gut microbiota composition by serotonin signaling influences intestinal immune response and susceptibility to colitis. Cell Mol Gastroenterol Hepatol 7(4):709\u2013728. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.01.004","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"3546_CR119","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X et al (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185(6):3190\u20133198. https:\/\/doi.org\/10.4049\/jimmunol.0903670","journal-title":"J Immunol"},{"issue":"6","key":"3546_CR120","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCG.0b013e3182549092","volume":"46","author":"F Guarner","year":"2012","unstructured":"Guarner F, Khan AG, Garisch J et al (2012) World gastroenterology organisation global guidelines: probiotics and prebiotics october 2011. J Clin Gastroenterol 46(6):468\u2013481. https:\/\/doi.org\/10.1097\/MCG.0b013e3182549092","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"3546_CR121","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","volume":"34","author":"SH Xin","year":"2018","unstructured":"Xin SH, Tan L, Cao X (2018) Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res 34(3):733\u2013748. https:\/\/doi.org\/10.1007\/s12640-018-9895-1","journal-title":"Neurotox Res"},{"issue":"24","key":"3546_CR122","doi-asserted-by":"publisher","first-page":"21895","DOI":"10.1074\/jbc.M008511200","volume":"276","author":"K Shirotani","year":"2001","unstructured":"Shirotani K, Tsubuki S, Iwata N et al (2001) Neprilysin degrades both amyloid \u03b2 peptides 1\u201340 and 1\u201342 most rapidly and efficiently among thiorphan-and phosphoramidon-sensitive endopeptidases. J Biol Chem 276(24):21895\u201321901. https:\/\/doi.org\/10.1074\/jbc.M008511200","journal-title":"J Biol Chem"},{"key":"3546_CR123","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/383796","volume":"2012","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva NN, Belyaev ND, Zhuravin IA (2012) The Alzheimer\u2019s amyloid-degrading peptidase, neprilysin: can we control it? Int J Alzheimer Dis 2012:383796. https:\/\/doi.org\/10.1155\/2012\/383796","journal-title":"Int J Alzheimer Dis"},{"issue":"1","key":"3546_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0640-z","volume":"6","author":"C Klein","year":"2018","unstructured":"Klein C, Roussel G, Brun S (2018) 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):1\u201315","journal-title":"Acta Neuropathol Commun"},{"key":"3546_CR125","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40478-018-0640-z","volume":"8","author":"M Ries","year":"2016","unstructured":"Ries M, Sastre M (2016) Mechanisms of A\u03b2 clearance and degradation by glial cells. Front Aging Neurosci 8:160. https:\/\/doi.org\/10.1186\/s40478-018-0640-z","journal-title":"Front Aging Neurosci"},{"key":"3546_CR126","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-018-0640-z","volume":"5","author":"MO Grimm","year":"2013","unstructured":"Grimm MO, Mett J, Stahlmann CP (2013) Neprilysin and A\u03b2 clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer\u2019s disease. Front Aging Neurosci 5:98. https:\/\/doi.org\/10.1186\/s40478-018-0640-z","journal-title":"Front Aging Neurosci"},{"key":"3546_CR127","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41392-020-0188-9","volume":"5","author":"Z Duan","year":"2020","unstructured":"Duan Z, Zhang S, Liang H et al (2020) Amyloid \u03b2 neurotoxicity is IDO1\u2013Kyn\u2013AhR dependent and blocked by IDO1 inhibitor. Signal Transduct Target Ther 5:96. https:\/\/doi.org\/10.1038\/s41392-020-0188-9","journal-title":"Signal Transduct Target Ther"},{"key":"3546_CR128","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bbi.2020.01.015","volume":"87","author":"MG Morgese","year":"2020","unstructured":"Morgese MG, Schiavone S, Maffione AB (2020) Depressive-like phenotype evoked by lifelong nutritional omega-3 deficiency in female rats: crosstalk among kynurenine, toll-like receptors and amyloid beta oligomers. Brain Behav Immun 87:444\u2013454. https:\/\/doi.org\/10.1016\/j.bbi.2020.01.015","journal-title":"Brain Behav Immun"},{"key":"3546_CR129","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ics.2007.07.012","volume":"1304","author":"GJ Guillemin","year":"2007","unstructured":"Guillemin GJ, Brew BJ, Noonan CE (2007) Mass spectrometric detection of quinolinic acid in microdissected Alzheimer\u2019s disease plaques. Int Corros Conf Ser 1304:404\u2013408. https:\/\/doi.org\/10.1016\/j.ics.2007.07.012","journal-title":"Int Corros Conf Ser"},{"issue":"3","key":"3546_CR130","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1189\/jlb.0303114","volume":"75","author":"GJ Guillemin","year":"2004","unstructured":"Guillemin GJ, Brew BJ (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 75(3):388\u2013397. https:\/\/doi.org\/10.1189\/jlb.0303114","journal-title":"J Leukoc Biol"},{"key":"3546_CR131","doi-asserted-by":"publisher","DOI":"10.4137\/ijtr.s2129","author":"DM Richard","year":"2009","unstructured":"Richard DM, Dawes MA, Mathias CW (2009) L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J Tryptophan Res. https:\/\/doi.org\/10.4137\/ijtr.s2129","journal-title":"Int J Tryptophan Res"},{"key":"3546_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","volume":"80","author":"KR Jacobs","year":"2019","unstructured":"Jacobs KR, Lim CK, Blennow K et al (2019) Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau. Neurobiol Aging 80:11\u201320. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.03.015","journal-title":"Neurobiol Aging"},{"key":"3546_CR133","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-020-00741-z","volume":"13","author":"L Whiley","year":"2021","unstructured":"Whiley L, Chappell KE, D\u2019Hondt E et al (2021) Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer\u2019s disease. Alz Res Therapy 13:20. https:\/\/doi.org\/10.1186\/s13195-020-00741-z","journal-title":"Alz Res Therapy"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03546-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03546-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03546-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T07:08:53Z","timestamp":1653116933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03546-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3546"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03546-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}